Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
about
Phosphonoformic Acid Inhibits Viral Replication by Trapping the Closed Form of the DNA PolymeraseAntiviral drug resistance: mechanisms and clinical implicationsAntiviral drug resistance of human cytomegalovirus.Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping.Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation.A model of human cytomegalovirus infection in severe combined immunodeficient mice.The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymeraseThe search for new therapies for human cytomegalovirus infections.Management of multidrug-resistant viruses in the immunocompromised host.Therapeutic strategies for the prevention and treatment of cytomegalovirus infection.Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review.Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet.Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Differentiation between polymorphisms and resistance-associated mutations in human cytomegalovirus DNA polymerase.Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure.Foscarnet-resistant cytomegalovirus esophagitis with stricturing.Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens.UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locus.Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
P2860
Q27667828-CE44ECAC-318A-48C3-B047-B4FD58239FF4Q28282376-D3DD0E7D-7A70-4D51-9F96-3EAE246AB736Q30430427-24B7AB24-8CF9-46A5-BC15-5B2149B5BBBEQ34034462-E1C332EC-624E-4E84-9ABD-441DD92D9169Q34687313-FEACBB36-5B5C-489D-AF3E-1057150179D3Q35036076-2D1DA934-3E3C-4659-B5E4-DC2823D6FA27Q35661025-0541D53D-B409-4469-9B28-1EB7BF787DD1Q36177655-35917905-D27F-4CA2-9520-BEA6FB5EF2A0Q37173390-91430DED-D23E-44FF-AAA8-216610333BFBQ37523020-4CB7577E-FB02-435D-9C51-FE575FABDD36Q37811458-C22A8DD0-EED4-4453-9E45-4DBFADF207DDQ37970424-9EE3EA40-D17E-427D-AA43-C864C7CB7670Q38014916-88BF0C2F-4A60-41A4-898D-8C3542B1D32EQ38260298-96C7873F-5905-452A-96D1-2C89CD13076CQ38282979-7F68A443-7A3D-440B-8E05-6BA5BA67DF72Q38370342-1164BF76-8DE7-4FB4-A4A6-421DBA4C5ED2Q38631773-DE83B0B8-E247-4B5B-BBCC-4C53544A3552Q38779846-1C3072F3-8EF7-4064-98EA-514EAF93872BQ39650785-ADE56534-870A-4AA1-8188-0D14F0D349EDQ40325104-0C8A35CF-1C6F-4941-992F-5BE553ADFC53Q42018386-786EC6FF-54C2-4055-85C1-F0CC8CBA1172Q42177603-36287712-7CC3-48F1-BE78-DF978603E9BAQ42224425-A3908A61-7398-4B69-A209-587D5D6154BAQ42852632-F73A8DFC-8F8A-4A68-87A0-D98EF6DC64BDQ43248439-C3E0721B-5F3A-4A59-91D5-8F61C72D9089Q46639393-7B01E5E2-BA18-452B-B9BC-577BCAA9F6EA
P2860
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@ast
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@en
type
label
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@ast
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@en
prefLabel
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@ast
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@en
P2093
P2860
P921
P356
P1476
Multidrug resistance conferred ...... uman cytomegalovirus isolates.
@en
P2093
Adriana Weinberg
Gillian M Scott
Sunwen Chou
P2860
P356
10.1128/AAC.00633-06
P407
P577
2006-10-16T00:00:00Z